Electra Therapeutics, Inc. Common stock (ETRA) is a publicly traded the market company. As of November 6, 2026, ETRA trades at $7.62 with a market cap of $500.25M and a P/E ratio of 0.00. ETRA moved -8.41% today. Year to date, ETRA is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $6.87 to $15.50. Analyst consensus is strong buy with an average price target of $32.67. Rallies surfaces ETRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
5 analysts cover ETRA: 0 strong buy, 5 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $32.67.
| Metric | Value |
|---|---|
| Price | $7.62 |
| Market Cap | $500.25M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.50 |
| 52-Week Low | $6.87 |
| Volume | 485.65K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover ETRA: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $32.67.